Latest articles
Stanford Biodesign fellows hope to spur innovation in home countries
A new, artistic perspective on plastic waste
What’s the deali-O Part 2: Navigating new weight loss drugs
Popular Articles
Rethinking hospital diets: personalized, healthy, real food
Stanford Medicine doctors, dietitians and nutritionists rethink what it means to have healthy food for hospital patients.
What’s the deali-O Part 2: Navigating new weight loss drugs
Stanford Medicine obesity experts discuss the pros and cons of semaglutide, the active ingredient in Ozempic and other weight loss drugs.
What’s the deali-O with new weight loss drugs? Part 1
Stanford Medicine researchers weigh in on the promise and peril of increasingly popular diabetes drugs being used for weight loss.